![Stephen Prior](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Prior
Geen lopende functies
Vermogen: 327 927 $ op 31-08-2026
Profiel
Stephen D.
Prior is the founder of DynPort Vaccine Co. LLC.
Former jobs include Executive Director at National Defense University from 2006 to 2024, Chief Strategy Officer at AN2 Therapeutics, Inc., and Chief Scientific Officer at Exponential Biotherapies, Inc. Education includes a doctorate from the University of Warwick and an undergraduate degree from the University of Kent.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-01-2026 | 59.086 ( 0,16% ) | 327 927 $ | 31-08-2026 |
Eerdere bekende functies van Stephen Prior
| Bedrijven | Functie | Einde |
|---|---|---|
National Defense University
 National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-12-2024 |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Oprichter | - |
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Stephen Prior
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical, vaccine and medical product development & licensure services | Commercial Services |
National Defense University
National Defense University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
